Biosimilar Newsletter Archive

  1. 02.28.19 -- Why Medicare's IPI Will Challenge Biosimilars, Payers
    2/28/2019
    02/28/19 Biosimilar Development Newsletter
  2. 02.21.19 -- Why This U.S. Biosimilar Initiative Is One To Watch
    2/21/2019
    02/21/19 Biosimilar Development Newsletter
  3. 02.14.19 -- Biosimilar Sustainability Requires A Step-Wise Approach
    2/14/2019
    02/14/19 Biosimilar Development Newsletter
  4. 02.07.19 -- How Has Biosimilar Real-World Evidence Evolved?
    2/7/2019
    02/07/19 Biosimilar Development Newsletter
  5. 02.05.19 -- Biomanufacturing Facility Design: Considerations For Capacity, Flexibility, And Forecasting
    2/5/2019
    02/05/19 Biosimilar Development Newsletter
  6. 02.02.19 -- Employers & Biosimilars: Closing The Gap
    2/2/2019
    02/02/19 Biosimilar Development Newsletter
  7. 01.31.19 -- Experts Discuss Biggest 2019 Biosimilar Challenges
    1/31/2019
    01/31/19 Biosimilar Development Newsletter
  8. 01.24.19 -- 2018: The Year Of Biosimilar Real-World Evidence
    1/24/2019
    01/24/19 Biosimilar Development Newsletter
  9. 01.17.19 -- How Will The FDA Shutdown Impact Pharma?
    1/17/2019
    01/17/19 Biosimilar Development Newsletter
  10. 01.16.19 -- Raw Material Management: Working Together To Overcome Variability
    1/16/2019
    01/16/19 Biosimilar Development Newsletter